What are the potential advantages and disadvantages of tokenizing the biopharmaceutical supply chain?

1 answers

• Gerardo QuintanaFeb 14, 2021 · 5 years ago
  Tokenizing the biopharmaceutical supply chain offers several advantages. It can improve supply chain efficiency by reducing paperwork, eliminating intermediaries, and enabling real-time tracking of products. This can lead to cost savings and faster delivery of drugs to patients. Tokenization also has the potential to democratize investment in the biopharmaceutical industry, allowing individuals to invest in specific drugs or research projects. However, there are challenges to consider. Regulatory compliance is a major concern, as the biopharmaceutical industry is subject to strict regulations. Tokenization also requires a high level of technical expertise and infrastructure, which may pose barriers to adoption. Furthermore, the reliance on blockchain technology introduces new risks, such as smart contract vulnerabilities and potential for data breaches.
  865

  433